Driving innovative solutions with
In April 2017, we acquired Adhesys Medical and its innovative pipeline of surgical sealants alongside the supporting technology. The technology fulfils our desire to go beyond drug development to drive genuine innovation.
This acquisition provided us with a truly unique technology platform. The surgical sealants could provide alternatives to the traditional methods for closing both wounds to the skin and inside the body during surgery. In addition, the combination of the technology’s bonding strength, fast sealing and flexibility is not currently available in any other product.
Our acquisition represented the perfect marriage; the deep know how, entrepreneurial spirit and high agility of Adhesys Medical, combined with our unique experience of running tailored clinical programmes to bring new solutions to the market in complex cross-functional settings.